Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Manufacturers push for legal clarity at FDA's first public hearing on CBD

June 3, 2019, Food Dive

Brian Sylvester spoke with Food Dive about the push from manufacturers for clarity at the FDA’s first public hearing on CBD. Mr. Sylvester says that in the short term, the FDA could issue a policy statement that says if a company is marketing food or dietary supplements with compounds like CBD and it is derived from hemp, which is legal now because of the Farm Bill, then they will not take action. This would give manufacturers more regulatory certainty. But ultimately, the FDA could go through the rulemaking process which would take at least two years.

“Based on consumer demand, FDA has recognized that consumers are looking for these types of products in the marketplace and they are willing now to work with industry stakeholders to develop a predictable and lawful pathway to market these products,” he adds.

Share this article: